- |||||||||| naltrexone low dose (STAT-205) / Statera BioPharma
Biomarker, Enrollment open, Phase classification, Enrollment change, Trial completion date, Trial initiation date, Trial primary completion date: Single-Blind Study of STAT-205 in Mild COVID-19 (clinicaltrials.gov) - Dec 22, 2021
P1, N=24, Recruiting,
Not yet recruiting --> Recruiting | Phase classification: P2 --> P1 | N=75 --> 24 | Trial completion date: Apr 2022 --> Sep 2022 | Initiation date: Apr 2021 --> Dec 2021 | Trial primary completion date: Apr 2022 --> Jun 2022
|
